Industry News
Pharmaceutical Industry News
Biden Tries to Reassure Voters on Health Care Costs Before Election
At an event in Southern California, the president says his administration is working to keep costs down and warns that Republicans will drive prices higher if they gain power.
What A.L.S. and Alzheimer’s Drug Approvals Have in Common
Regulators must balance patient’s needs with their safety.
F.D.A. Confirms Widespread Shortages of Adderall
The agency cited Teva’s continuing supply problems as well as those of other drug makers struggling to fill the gap.
¿Las nuevas vacunas contra la malaria podrán erradicarla?
Dos nuevas vacunas finalmente pueden hacer retroceder al antiguo flagelo. Pero, de manera inesperada, su llegada también complica el camino para acabar con la enfermedad.
Can New Vaccines Finally Eradicate Malaria?
Two new vaccines may finally turn back an ancient plague. But in unexpected ways, their arrival also complicates the path to ending the disease.
Price of New A.L.S. Treatment Will Be $158,000 Per Year, Maker Says
The list price of the therapy, Relyvrio, is much higher than an economic research group recommends, but the company says most patients will pay very little themselves.
Un nuevo tratamiento contra el VIH ha probado ser un éxito. ¿Será accesible en África?
Durante varios años ha existido en Sudáfrica una pastilla que se debe tomar todos los días para prevenir el virus. Ahora existe una inyección cada dos meses, un método mucho más accesible, pero aún no
FDA Approves ALS Treatment Despite Questions About Effectiveness
The drug is safe, and one trial found it may extend survival and slow paralysis in functions like muscle control and speaking. A larger trial will be completed in 2024.
Alzheimer’s Drug Slows Cognitive Decline in Key Study
Biogen and Eisai reported the finding from a large late-stage clinical trial of lecanemab, a drug they are developing.
Covid Boosters
Who should get a Covid booster, and when? We answer the big questions.
A New Shot Guards Against H.I.V., but Access for Africans Is Uncertain
An injection every two months rather than a daily pill could shield many more women from the virus, but it is unavailable in places that need it most.
Biogen Agrees to Pay $900 Million to Settle Lawsuit Over Kickbacks
The company was accused of illegally paying doctors to prescribe its drugs over those of its rivals.
La salud mental es política
Hay una crisis de salud mental en EE. UU. Y el primer paso para resolverla es hacer preguntas incómodas a quienes están en el poder.
Monkeypox Appears to Recede, but Risks and Uncertainties Linger
Scientists do not yet know how well the vaccine and the drug used to treat the infection are working. Two new trials will provide answers.
Weekly Health Quiz: Broken Hearts, Anxiety and Exercise
Test your knowledge of this week’s health news.
F.D.A. Warning on NyQuil Chicken Alerts Many to Existence of NyQuil Chicken
Cooking poultry in cold medicine is a bad, dangerous idea that few people seemed to be aware of until the government warning attracted media coverage.
Is America Really in a Mental Health Crisis?
Many in power would prefer to kick questions like “What caused the mental health crisis?” and “Who benefits?” out of sight. Don’t let them.
What Joe Biden Knows That No One Expected Him To
A liberalism that is as ambitious about solving problems through invention as it is through redistribution would be powerful indeed.
FDA’s Drug Industry Fees Fuel Concerns Over Influence
The pharmaceutical industry finances about 75 percent of the agency’s drug division, through a controversial program that Congress must reauthorize by the end of this month.
Monkeypox Shots, Treatments and Tests Are Unavailable in Much of the World
High-income countries snapped up vaccines when the disease hit them, leaving none for countries that have battled the virus for years, in an echo of the Covid response.